Vivos Therapeutics (VVOS) Asset Utilization Ratio (2021 - 2025)
Vivos Therapeutics (VVOS) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.67 as the latest value for Q3 2025.
- On a quarterly basis, Asset Utilization Ratio fell 28.32% to 0.67 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.67, a 28.32% decrease, with the full-year FY2024 number at 1.16, up 2.36% from a year prior.
- Asset Utilization Ratio was 0.67 for Q3 2025 at Vivos Therapeutics, down from 0.77 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.31 in Q4 2023 to a low of 0.36 in Q3 2021.
- A 5-year average of 0.84 and a median of 0.94 in 2024 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: soared 120.74% in 2022, then dropped 28.32% in 2025.
- Vivos Therapeutics' Asset Utilization Ratio stood at 0.45 in 2021, then skyrocketed by 120.74% to 1.0 in 2022, then skyrocketed by 31.44% to 1.31 in 2023, then fell by 25.16% to 0.98 in 2024, then tumbled by 31.71% to 0.67 in 2025.
- Per Business Quant, the three most recent readings for VVOS's Asset Utilization Ratio are 0.67 (Q3 2025), 0.77 (Q2 2025), and 1.1 (Q1 2025).